Regen BioPharma Inc

Regen BioPharma Inc focuses on the development of regenerative medical applications in the United States It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications and immune cell suppression for autoimmune disease The company is in the early stages of development of its products and therapies Regen BioPharma Inc was incorporated in 2012 and is based in La Mesa California